T2DM is a heterogeneous, progressive metabolic condition defined by tissue insulin resistance, insufficient compensatory insulin production, and faulty insulin secretion by pancreatic beta-cells [1]. This evidence concerns the gene INS and type 2 diabetes mellitus.